ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico ''Long-term impact of RAS inhibition on cardiorenal outcomes-LIRICO"

Translated title of the contribution: Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO)

A. Maione, A. Nicolucci, J. C. Craig, G. Tognoni, A. Moschetta, G. Palasciano, G. Pugliese, D. A. Procaccini, L. Gesualdo, F. Pellegrini, G. F M Strippoli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO)'. Together they form a unique fingerprint.

Medicine & Life Sciences